These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
105 related items for PubMed ID: 8061851
1. Angiotensin-converting enzyme inhibition with spirapril in patients with coronary artery disease. Thürmann P, Rietbrock N. Blood Press Suppl; 1994; 2():73-6. PubMed ID: 8061851 [Abstract] [Full Text] [Related]
2. Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease. Winkelmann BR, Matheis G, Kleist P, Pötter S, Wohltmann D, Kaltenbach M. Coron Artery Dis; 1994 Oct; 5(10):829-44. PubMed ID: 7866603 [Abstract] [Full Text] [Related]
3. [Treatment of chronic stable angina pectoris with angiotensin converting enzyme inhibition--a randomized, placebo-controlled, double-blind cross-over study]. Odenthal HJ, Thürmann P, Wiechmann HW, Josephs W, Lenga P. Z Kardiol; 1991 Jun; 80(6):392-6. PubMed ID: 1926985 [Abstract] [Full Text] [Related]
4. [Anti-ischemia effect of enalapril in coronary heart disease. A randomized placebo-controlled double-blind study]. Rietbrock N, Thürmann P, Kirsten R, Schneider W. Dtsch Med Wochenschr; 1988 Feb 26; 113(8):300-2. PubMed ID: 2830091 [Abstract] [Full Text] [Related]
5. [A Czech and Slovak interventional study of spirapril (the CASSIS study). A randomized, double-blind, multicenter, placebo-controlled study in chronic heart failure]. Jerie P, Kremer HJ, Uhlír O, Widimský J. Vnitr Lek; 1997 Jun 26; 43(6):351-8. PubMed ID: 9601863 [Abstract] [Full Text] [Related]
6. Placebo-controlled comparison of spirapril at 6, 12 and 24 mg/day in mild to severe essential hypertension. Guitard C, Alvisi V, Maibach E, Franck J, Cocco G, Boxho G, Mellein B, Waite R. Blood Press Suppl; 1994 Jun 26; 2():81-7. PubMed ID: 8061853 [Abstract] [Full Text] [Related]
8. The effect of an angiotensin-converting enzyme inhibitor and a K+(ATP) channel opener on warm up angina. Edwards RJ, Redwood SR, Lambiase PD, Marber MS. Eur Heart J; 2005 Mar 26; 26(6):598-606. PubMed ID: 15618027 [Abstract] [Full Text] [Related]
9. A multicentre multidose study of the efficacy and safety of spirapril in mild-to-moderate essential hypertension. UK Study Group of Spirapril in Hypertension. Fairhurst GJ. Blood Press Suppl; 1994 Mar 26; 2():77-80. PubMed ID: 8061852 [Abstract] [Full Text] [Related]
18. Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors. McMahon FG, Weinstein SP, Rowe E, Ernst KR, Johnson F, Fujioka K, Sibutramine in Hypertensives Clinical Study Group. J Hum Hypertens; 2002 Jan 26; 16(1):5-11. PubMed ID: 11840224 [Abstract] [Full Text] [Related]
20. Effects of spirapril and captopril on regional blood flow in chronic congestive heart failure: a comparison between a short- and a long-acting angiotensin-converting enzyme inhibitor. van den Broek SA, de Graeff PA, Smit AJ, Girbes AR, Journée, van Gilst WH, Hillege H, van Veldhuisen DJ, Wesseling H, Lie KI. J Cardiovasc Pharmacol; 1995 Jan 26; 25(1):105-12. PubMed ID: 7723338 [Abstract] [Full Text] [Related] Page: [Next] [New Search]